抗磷脂抗体综合征患者对华法林治疗耐药时使用低分子量肝素的长期治疗 - Suppr

Suppr

超能文献

Long-duration therapy with low molecular weight heparin in patients with antiphospholipid antibody syndrome resistant to warfarin therapy.

作者信息

Dentali F, Manfredi E, Crowther M, Ageno W

出版信息

J Thromb Haemost. 2005 Sep;3(9):2121-3. doi: 10.1111/j.1538-7836.2005.01516.x.

DOI:10.1111/j.1538-7836.2005.01516.x

PMID:16102129

Abstract

摘要

相似文献

Long-duration therapy with low molecular weight heparin in patients with antiphospholipid antibody syndrome resistant to warfarin therapy.

J Thromb Haemost. 2005 Sep;3(9):2121-3. doi: 10.1111/j.1538-7836.2005.01516.x.

Low-molecular weight heparin: treatment failure in a patient with primary antiphospholipid antibody syndrome.

Am J Med Sci. 2002 Nov;324(5):279-80. doi: 10.1097/00000441-200211000-00008.

Efficacy and safety of long-term low molecular weight heparin in patients with antiphospholipid syndrome.

Ann Rheum Dis. 2011 Sep;70(9):1652-4. doi: 10.1136/ard.2011.150268. Epub 2011 May 30.

Pregnancy-associated recurrent liver necrosis in patient with antiphospholipid syndrome.

Lupus. 2006;15(12):889-91. doi: 10.1177/0961203306072385.

Treatment and monitoring of patients with antiphospholipid antibodies and thrombotic history (Hughes syndrome).

Curr Rheumatol Rep. 2002 Oct;4(5):392-8. doi: 10.1007/s11926-002-0083-0.

[Treatment of antiphospholipid syndrome].

Rev Med Univ Navarra. 2007 Oct-Dec;51(4):38-41.

Successful use of fondaparinux in a child with heparin-induced thrombocytopenia.

Blood Coagul Fibrinolysis. 2012 Dec;23(8):769-71. doi: 10.1097/MBC.0b013e328358afc9.

The use of fondaparinux and rituximab for recurrent thrombotic events in antiphospholipid syndrome.

Lupus. 2022 Oct;31(12):1485-1490. doi: 10.1177/09612033221122147. Epub 2022 Sep 8.

Prevention of fetal loss in experimental antiphospholipid syndrome by low-molecular-weight heparin.

Am J Obstet Gynecol. 1993 Aug;169(2 Pt 1):423-6. doi: 10.1016/0002-9378(93)90100-w.

Effects of unfractionated and low molecular weight heparin on antiphospholipid antibody binding in vitro.

Obstet Gynecol. 2003 Mar;101(3):455-62. doi: 10.1016/s0029-7844(02)02520-6.

引用本文的文献

A Patient with Recurrent Strokes: Approach to Coagulopathy.

TH Open. 2023 Sep 27;7(3):e262-e269. doi: 10.1055/a-2161-1262. eCollection 2023 Jul.

Role of Direct Oral Anticoagulation Agents as Thromboprophylaxis in Antiphospholipid Syndrome.

Cureus. 2021 Oct 24;13(10):e19009. doi: 10.7759/cureus.19009. eCollection 2021 Oct.

A Difficult and Rare Case of Warfarin Refractory Antiphospholipid Syndrome Presenting With Catastrophic Antiphospholipid Syndrome Complicated by Gastrointestinal Bleeding.

Cureus. 2021 Aug 11;13(8):e17106. doi: 10.7759/cureus.17106. eCollection 2021 Aug.

Case Report: Resetting the Humoral Immune Response by Targeting Plasma Cells With Daratumumab in Anti-Phospholipid Syndrome.

Front Immunol. 2021 Apr 12;12:667515. doi: 10.3389/fimmu.2021.667515. eCollection 2021.

Diagnosis and management of the antiphospholipid syndrome.

Blood Rev. 2017 Nov;31(6):406-417. doi: 10.1016/j.blre.2017.07.006. Epub 2017 Jul 30.

Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management-An Insight into Future Approaches.

J Immunol Res. 2015;2015:951424. doi: 10.1155/2015/951424. Epub 2015 May 5.

Difficult clinical situations in the antiphospholipid syndrome.

Curr Rheumatol Rep. 2015 Apr;17(4):29. doi: 10.1007/s11926-015-0502-7.

Practical issues with vitamin K antagonists: elevated INRs, low time-in-therapeutic range, and warfarin failure.

J Thromb Thrombolysis. 2011 Apr;31(3):249-58. doi: 10.1007/s11239-011-0555-z.

Intensity of warfarin coagulation in the antiphospholipid syndrome.

Curr Rheumatol Rep. 2010 Feb;12(1):64-9. doi: 10.1007/s11926-009-0070-9.

New approaches for managing antiphospholipid syndrome.

Nat Clin Pract Rheumatol. 2009 Mar;5(3):160-70. doi: 10.1038/ncprheum1017.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验